LAPTM5 and neoplasm: A qRT-PCR analysis of paired ESCC samples (primary tumors and their corresponding non-cancerous tissues) revealed a more than 30% reduction of LAPTM5 expression in primary tumor tissues compared with the corresponding non-cancerous tissues in 12 of the 32 cases (37.5%) (Figure 1B).